Finally, we validated these findings at the transcript and protein level in two independent AD cohorts, demonstrating that expression of the DAC protein DTNA (dystrobrevin) and the candidate endfoot protein MLC1 (megalencepalic leukoencephalopathy with subcortical cysts 1) predicts AD status and are associated with cortical tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.